Prospective comparison of hormone withdrawal symptoms of a 24/4 regimen with a 21/7 regimen of OC.
Phase of Trial: Phase II
Latest Information Update: 24 Mar 2010
At a glance
- Drugs Ethinylestradiol/norethisterone (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- 25 Nov 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Apr 2008 Status changed from recruiting to in progress, reported by ClinicalTrials.gov.
- 30 Jul 2007 Status changed from initiated to recruiting.